Clin2
NCT05587361Possibly a fitRecruiting

Nicotine cue study using propranolol to study craving

Tobacco Use DisorderNicotine DependenceCigarette Smoking

Treatments studied

Part of Mental health clinical trials.

This study tests whether a beta-blocking medicine (propranolol) and nicotine patches change how strongly your brain responds to smoking cues. It may help researchers understand what drives cigarette cravings and how to reduce them.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
80 people
Ages
21 years to 60 years
Study type
Interventional

Who can take part

  • Age 21 to 60
  • Smoke at least 5 cigarettes per day every day for at least 1 year, with stable smoking for the last 6 months
  • Have proof of smoking in your tests (expired carbon monoxide of 6+ ppm and/or a urine nicotine level above 100 ng/mL)
  • Be able to attend all study visits and complete required tasks
  • Use English well enough to read and understand study materials
  • Be right-handed (per a short set of questions)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07698470Recruiting
Brain response to smoking cues after using nicotine pouches

This study looks at how your brain reacts to smoking cues after using an oral nicotine pouch. You would need to try the pouch and avoid nicotine for 12 hours before each session.

Los Angeles, California
NCT07812753Recruiting
Brain stimulation for smoking cessation

This study looks at how a non-invasive brain stimulation technique called TMS (which uses magnetic pulses to stimulate the brain) might affect the brain's reward system in people who smoke. The goal is to understand how to help people quit smoking more effectively.

Newark, New Jersey
NCT06798324Recruiting· Phase 4
Brain stimulation plus smoking cessation medication for quitting smoking

This trial tests whether combining brain stimulation (tDCS) with a smoking cessation medication (varenicline) helps people quit smoking. You would attend daily visits for two weeks.

Toronto, Ontario
NCT07564648Recruiting
Menthol Cigarette Study: How Different Brands Affect Smoking

This study compares how your body and mind respond to your usual menthol cigarettes versus a new menthol cigarette. Researchers want to understand how different menthol cigarettes affect smoking behavior and cravings over two weeks.

Columbus, Ohio
NCT06617312Recruiting· Phase 2
Cytisinicline and brain response to smoking cues

This study tests how a medicine called cytisinicline (similar to a plant-based stop-smoking aid) affects brain activity when you see or think about smoking. It may help researchers understand how the medicine works, even if you aren't ready to quit right now.

Los Angeles, California
NCT05766553Recruiting
Virtual reality mindfulness to reduce cigarette cravings

This trial tests whether guided mindfulness meditation in virtual reality can lower cigarette cravings and help people quit smoking. It may help by reducing urges to smoke during stressful moments.

Iteuil

Hear when a new Tobacco Use Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.